Moderna Seeks US FDA Authorization for its Covid-19 Booster


On Wednesday, 1st September 2021, the company ‘Moderna’ have asked the US FDA for allowing the use of a third booster dose of the company’s novel corona virus vaccine, and the US FDA has now been considering the booster shots of the Pfizer covid-19 vaccine, but until now the FDA has only allowed the people, who are having weak immune systems for receiving the third doses of any of the two booster shots of Pfizer and Moderna.

On Wednesday, 1st September 2021, US FDA said, a group of the advisors of the agency are going to be meeting for the purpose of discussing the covid-19 booster shot application of Pfizer on 17th September 2021, but it is still not clear whether they are going to be discussing the vaccine shots of Moderna.

The company ‘Moderna’ said, it has already submitted the initial data for the use of a booster dose of the corona virus vaccine, and the original covid-19 vaccine developed by Moderna is now containing 100 micrograms of the mRNA in each shot, and the recipients of this vaccine dose are having some robust antibody responses against the Delta Variant of the novel corona virus.

READ  Tesla To Increase Price for Its Full Self-Driving Technology in North America

Stephane Bancel, chief executive of Moderna said, the company is having its novel corona virus vaccine had still been about 93 percent more effective just 6 months after the second, and it has also been observed that, the levels of antibody had now been waning significantly at the point.